Effect of particle size on liver MRI relaxometry: Monte Carlo simulation and phantom studies
- PMID: 38725136
- PMCID: PMC11262983
- DOI: 10.1002/mrm.30154
Effect of particle size on liver MRI relaxometry: Monte Carlo simulation and phantom studies
Abstract
Purpose: To investigate the effect of particle size on liver by Monte Carlo simulation and phantom studies at both 1.5 T and 3.0 T.
Methods: Two kinds of particles (i.e., iron sphere and fat droplet) with varying sizes were considered separately in simulation and phantom studies. MRI signals were synthesized and analyzed for predicting , based on simulations by incorporating virtual liver model, particle distribution, magnetic field generation, and proton movement into phase accrual. In the phantom study, iron-water and fat-water phantoms were constructed, and each phantom contained 15 separate vials with combinations of five particle concentrations and three particle sizes. measurements in the phantom were made at both 1.5 T and 3.0 T. Finally, differences in predictions or measurements were evaluated across varying particle sizes.
Results: In the simulation study, strong linear and positively correlated relationships were observed between predictions and particle concentrations across varying particle sizes and magnetic field strengths ( ). The relationships were affected by iron sphere size ( ), where smaller iron sphere size yielded higher predicted , whereas fat droplet size had no effect on predictions ( ) for constant total fat concentration. Similarly, the phantom study showed that measurements were relatively sensitive to iron sphere size ( ) unlike fat droplet size ( ).
Conclusion: Liver is affected by iron sphere size, but is relatively unaffected by fat droplet size. These findings may lead to an improved understanding of the underlying mechanisms of relaxometry in vivo, and enable improved quantitative MRI phantom design.
Keywords: Monte Carlo simulations; fat droplet; iron; liver R2*; particle size; phantom.
© 2024 International Society for Magnetic Resonance in Medicine.
Conflict of interest statement
CONFLICTS OF INTEREST
The authors declare that they have no relevant conflict of interest. Unrelated to this work, Dr. Reeder has ownership interests in Calimetrix, Reveal Pharmaceuticals, Cellectar Biosciences, Elucent Medical, HeartVista, and RevOps, and Dr. Hernando has ownership interests in Calimetrix.
References
-
- Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol. 2011;55(4): 920–932. - PubMed
-
- Yokoo T, Browning JD. Fat and iron quantification in the liver: past, present, and future. Top Magn Reson Imaging. 2014;23(2): 73–94. - PubMed
-
- Batts KP. Iron overload syndromes and the liver. Mod Pathol. 2007;20(1): S31–S39. - PubMed
MeSH terms
Grants and funding
- R01-EB031886/NH/NIH HHS/United States
- R01 DK088925/DK/NIDDK NIH HHS/United States
- 82060328/National Natural Science Foundation of China
- K24DK102595/NH/NIH HHS/United States
- R01 DK083380/DK/NIDDK NIH HHS/United States
- R01 DK100651/DK/NIDDK NIH HHS/United States
- R01DK083380/NH/NIH HHS/United States
- K24 DK102595/DK/NIDDK NIH HHS/United States
- R01 EB031886/EB/NIBIB NIH HHS/United States
- R01DK088925/NH/NIH HHS/United States
- XJ201811/Grants for Scientific Research of BSKY from Anhui Medical University
- R01DK100651/NH/NIH HHS/United States
- 62001005/National Natural Science Foundation of China
- 2008085QH425/Anhui Provincial Natural Science Foundation
- 2023AH050636/Natural Science Research Project of Anhui Educational Committee
LinkOut - more resources
Full Text Sources